Whole genome sequence analysis for acute lymphoblastic leukaemia
Whole genome sequence analysis for acute lymphoblastic leukaemia
Use of mesenchymal stromal cells against graft-versus-host disease
Next generation sequencing and the monoclonal structure of multiple myeloma
Mouse models and proteomics tackling acute lymphoblastic leukaemia
How malignant cells in patients with CLL escape T-cell recognition
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy
MEK inhibitor, trametinib, improves progression free survival in melanoma
Drug development in small cell and non-small cell lung cancer
Early phase trial of ibrutinib for chronic lymphocytic leukaemia
How malignant cells in patients with CLL escape T-cell recognition
Clinical trials for rare tumour types
First line treatment against metastatic breast cancer